Latest balloon catheter Stories

WEBSTER, Texas, June 24 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme) GliderXtreme(TM) PTA balloon catheter, an advanced product with specific features for the expanding Peripheral Arterial Disease (PAD) market. The PAD market represents more...

PARIS, May 26 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the European approval and launch of its TREK(TM) Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year. "The TREK system has a more seamless,...

SAN DIEGO, May 26 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) announced today that it has received CE Mark approval for the VIBE(TM) RX Vascular Imaging Balloon Catheter. The company also announced that it has completed its first clinical cases with the VIBE(TM) RX in New Zealand. A single VIBE(TM) RX Catheter can quickly access, prepare, and assess challenging lesions. IVUS guidance provides precise, targeted balloon dilatation with immediate confirmation of...

NATICK, Mass., May 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced CE Mark and U.S. Food and Drug Administration (FDA) approval of its NC Quantum Apex(TM) PTCA Dilatation Balloon Catheter. The Company plans to launch the product in European markets this week and in the U.S. next month. The NC Quantum Apex Catheter is a high-performance, post-dilatation balloon catheter developed specifically to address physicians' needs in optimizing coronary stent...

SAN DIEGO, May 24 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) announced today the company's plans to highlight its new product launches, presence in live cases, and participation in late breaking trials during EuroPCR from May 25 - 28 in Paris. "Through both imaging and therapy, Volcano continues to lead the way in providing innovative solutions to best meet the complex needs of the interventional vascular physician and their patients," said Michel Lussier, Group President...

NATICK, Mass., May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launches of the Sterling(®) SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets. The Sterling SL Balloon Catheter was developed specifically to address physicians' needs in treating...

SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many...

PLEASANTON, Calif., Feb. 25 /PRNewswire/ -- TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for its newest product, the Glider(TM) balloon catheter, for percutaneous transluminal angioplasty (PTA) of lesions in the peripheral vasculature including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries. Approximately 12 million Americans are affected by peripheral arterial disease (PAD). Those patients suffer from chronic pain,...

WARRENDALE, Pa., Jan. 27 /PRNewswire/ -- MEDRAD, Inc. has entered into a co-marketing and trademark license agreement with B. Braun Melsungen AG (Melsungen, Germany) to promote the Paccocath® technology, a unique and clinically tested technology used to treat blocked vessels without stenting. The Paccocath technology has been shown in multiple clinical trials to keep the artery open wider (reduce late lumen loss) over time in patients with Peripheral Arterial Disease and Coronary Artery...

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Interventional Cardiology 2009 (15 Countries) http://www.reportlinker.com/p0166830/European-Markets-for-Interventional-Cardiology-2009-15-Countries.html In 2008, the European market for interventional cardiology was valued at over Euro1.5 billion. The interventional cardiology market includes drug-eluting stents, bare-metal stents, PTCA balloons,...